gemtuzumab ozogamicin
General
High Alert Medication: This medication bears a heightened risk of causing significant patient harm when it is used in error.
Genetic Implications:
Pronunciation:
gem-tu-zoo-mab o-zo-ga-my-sin
To hear audio pronunciation of this topic, purchase a subscription or log in.Trade Name(s)
- Mylotarg
Ther. Class.
Pharm. Class.
monoclonal antibodies
antitumor antibiotics
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Gemtuzumab Ozogamicin." Davis's Drug Guide, 19th ed., F.A. Davis Company, 2026. The Washington Manual, www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/51354/10.0/gemtuzumab_ozogamicin.
Vallerand AHA, Sanoski CAC, . Gemtuzumab ozogamicin. Davis's Drug Guide. F.A. Davis Company; 2026. https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/51354/10.0/gemtuzumab_ozogamicin. Accessed April 18, 2026.
Vallerand, A. H., Sanoski, C. A., & , (2026). Gemtuzumab ozogamicin. In Davis's Drug Guide (19th ed.). F.A. Davis Company. https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/51354/10.0/gemtuzumab_ozogamicin
Vallerand AHA, Sanoski CAC, . Gemtuzumab Ozogamicin [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2026. [cited 2026 April 18]. Available from: https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/51354/10.0/gemtuzumab_ozogamicin.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - gemtuzumab ozogamicin
ID - 51354
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - ,,
BT - Davis's Drug Guide
UR - https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/51354/10.0/gemtuzumab_ozogamicin
PB - F.A. Davis Company
ET - 19
DB - The Washington Manual
DP - Unbound Medicine
ER -

Davis's Drug Guide

